KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Other Working Capital Changes (2016 - 2025)

Humana (HUM) has disclosed Other Working Capital Changes for 16 consecutive years, with $716.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes changed N/A to $716.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 billion, a N/A change, with the full-year FY2024 number at $108.0 million, down 91.81% from a year prior.
  • Other Working Capital Changes was $716.0 million for Q3 2025 at Humana, up from -$28.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.1 billion in Q1 2021 to a low of -$1.1 billion in Q2 2021.
  • A 4-year average of $156.9 million and a median of $17.5 million in 2021 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: crashed 13525.0% in 2021, then surged 4955.56% in 2022.
  • Humana's Other Working Capital Changes stood at $26.0 million in 2021, then crashed by 107.69% to -$2.0 million in 2022, then soared by 400.0% to $6.0 million in 2023, then soared by 11833.33% to $716.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Other Working Capital Changes are $716.0 million (Q3 2025), -$28.0 million (Q2 2025), and $686.0 million (Q1 2025).